Consun Pharmaceutical Group Limited

SEHK:1681 주식 보고서

시가총액: HK$7.0b

Consun Pharmaceutical Group 관리

관리 기준 확인 3/4

Consun Pharmaceutical Group CEO는 Meng An, Jan2024 에 임명되었습니다 의 임기는 1년 미만입니다. 총 연간 보상은 CN¥ 19.79M, 5.5% 로 구성됩니다. 5.5% 급여 및 94.5% 보너스(회사 주식 및 옵션 포함). 는 HK$ 192.48M 가치에 해당하는 회사 주식의 2.74% 직접 소유합니다. 192.48M. 경영진과 이사회의 평균 재임 기간은 각각 4 년과 4 년입니다.

주요 정보

Meng An

최고 경영자

CN¥19.8m

총 보상

CEO 급여 비율5.5%
CEO 임기less than a year
CEO 소유권2.7%
경영진 평균 재임 기간4yrs
이사회 평균 재임 기간4yrs

최근 관리 업데이트

Recent updates

Consun Pharmaceutical Group Limited's (HKG:1681) Shares Leap 32% Yet They're Still Not Telling The Full Story

Oct 02
Consun Pharmaceutical Group Limited's (HKG:1681) Shares Leap 32% Yet They're Still Not Telling The Full Story

Here's Why Consun Pharmaceutical Group (HKG:1681) Has Caught The Eye Of Investors

Sep 26
Here's Why Consun Pharmaceutical Group (HKG:1681) Has Caught The Eye Of Investors

Consun Pharmaceutical Group (HKG:1681) Has A Rock Solid Balance Sheet

Jun 12
Consun Pharmaceutical Group (HKG:1681) Has A Rock Solid Balance Sheet

Consun Pharmaceutical Group's (HKG:1681) Dividend Will Be CN¥0.30

May 12
Consun Pharmaceutical Group's (HKG:1681) Dividend Will Be CN¥0.30

Consun Pharmaceutical Group (HKG:1681) Is Increasing Its Dividend To CN¥0.30

Jun 01
Consun Pharmaceutical Group (HKG:1681) Is Increasing Its Dividend To CN¥0.30

Consun Pharmaceutical Group (HKG:1681) Has A Rock Solid Balance Sheet

May 04
Consun Pharmaceutical Group (HKG:1681) Has A Rock Solid Balance Sheet

Consun Pharmaceutical Group (HKG:1681) Will Pay A Dividend Of HK$0.20

Apr 28
Consun Pharmaceutical Group (HKG:1681) Will Pay A Dividend Of HK$0.20

Consun Pharmaceutical Group (HKG:1681) Has Announced A Dividend Of HK$0.20

Apr 07
Consun Pharmaceutical Group (HKG:1681) Has Announced A Dividend Of HK$0.20

Consun Pharmaceutical Group (HKG:1681) Has Announced That It Will Be Increasing Its Dividend To HK$0.10

Aug 26
Consun Pharmaceutical Group (HKG:1681) Has Announced That It Will Be Increasing Its Dividend To HK$0.10

Consun Pharmaceutical Group (HKG:1681) Seems To Use Debt Rather Sparingly

Apr 21
Consun Pharmaceutical Group (HKG:1681) Seems To Use Debt Rather Sparingly

Does It Make Sense To Buy Consun Pharmaceutical Group Limited (HKG:1681) For Its Yield?

Mar 17
Does It Make Sense To Buy Consun Pharmaceutical Group Limited (HKG:1681) For Its Yield?

Here's Why Consun Pharmaceutical Group's (HKG:1681) Statutory Earnings Are Arguably Too Conservative

Feb 19
Here's Why Consun Pharmaceutical Group's (HKG:1681) Statutory Earnings Are Arguably Too Conservative

How Much Did Consun Pharmaceutical Group's(HKG:1681) Shareholders Earn From Share Price Movements Over The Last Three Years?

Jan 29
How Much Did Consun Pharmaceutical Group's(HKG:1681) Shareholders Earn From Share Price Movements Over The Last Three Years?

Could The Consun Pharmaceutical Group Limited (HKG:1681) Ownership Structure Tell Us Something Useful?

Jan 08
Could The Consun Pharmaceutical Group Limited (HKG:1681) Ownership Structure Tell Us Something Useful?

Consun Pharmaceutical Group (HKG:1681) Seems To Use Debt Quite Sensibly

Dec 18
Consun Pharmaceutical Group (HKG:1681) Seems To Use Debt Quite Sensibly

Should Consun Pharmaceutical Group Limited (HKG:1681) Be Part Of Your Income Portfolio?

Nov 18
Should Consun Pharmaceutical Group Limited (HKG:1681) Be Part Of Your Income Portfolio?

CEO 보상 분석

Meng An 의 보수는 Consun Pharmaceutical Group 의 수익과 비교하여 어떻게 변경되었나요?
날짜총 보상급여회사 수익
Jun 30 2024n/an/a

CN¥836m

Mar 31 2024n/an/a

CN¥810m

Dec 31 2023CN¥20mCN¥1m

CN¥785m

Sep 30 2023n/an/a

CN¥759m

Jun 30 2023n/an/a

CN¥734m

Mar 31 2023n/an/a

CN¥708m

Dec 31 2022CN¥17mCN¥1m

CN¥683m

Sep 30 2022n/an/a

CN¥660m

Jun 30 2022n/an/a

CN¥636m

Mar 31 2022n/an/a

CN¥613m

Dec 31 2021CN¥14mCN¥670k

CN¥590m

보상 대 시장: Meng 의 총 보상 ($USD 2.79M )은 Hong Kong 시장( $USD 505.49K ).

보상과 수익: Meng 의 보상은 지난 한 해 동안 회사 성과와 일치했습니다.


CEO

Meng An (53 yo)

less than a year

테뉴어

CN¥19,793,000

보상

Mr. Meng An serves as Executive Chairman of the Board at Consun Pharmaceutical Group Limited since July 9, 2021 and serves a sits Chief Executive Officer from January 17, 2024. Mr. An being the Chairman of...


리더십 팀

이름위치테뉴어보상소유권
Meng An
CEO & Executive Chairmanless than a yearCN¥19.79m2.74%
HK$ 192.5m
Quan Zhu
Chief Scientist & Executive Director4yrsCN¥742.00k데이터 없음
Hanxing Xu
Assistant GM3.7yrsCN¥774.00k데이터 없음
Peicheng Fang
CFO & VP4.7yrs데이터 없음데이터 없음
Lei Zhou
Assistant President4.8yrs데이터 없음데이터 없음
Haien Gao
Board Secretary10.6yrs데이터 없음데이터 없음
Chi Ming Yau
Company Secretary11.7yrs데이터 없음데이터 없음
Guorong Guo
Chairman & GM of Guangxi Yulin Pharmaceutical Group Co. Ltd4yrs데이터 없음데이터 없음
Lianhui Chen
Chairman & GM of Consun Pharmaceutical(Inner Mongolia) Co. Ltd4yrs데이터 없음데이터 없음

4.0yrs

평균 재임 기간

54yo

평균 연령

경험이 풍부한 관리: 1681 의 관리팀은 경험 ( 4 년 평균 재직 기간)으로 간주됩니다.


이사회 구성원

이름위치테뉴어보상소유권
Meng An
CEO & Executive Chairman3.7yrsCN¥19.79m2.74%
HK$ 192.5m
Quan Zhu
Chief Scientist & Executive Director11.9yrsCN¥742.00k데이터 없음
Hanxing Xu
Assistant GM3.7yrsCN¥774.00k데이터 없음
Guorong Guo
Chairman & GM of Guangxi Yulin Pharmaceutical Group Co. Ltd4yrs데이터 없음데이터 없음
Lianhui Chen
Chairman & GM of Consun Pharmaceutical(Inner Mongolia) Co. Ltd4yrs데이터 없음데이터 없음
Zhongshi Feng
Independent Non-Executive Director10.9yrsCN¥200.00k데이터 없음
Yujun Chen
Independent Non Executive Director5.5yrsCN¥200.00k데이터 없음
Lihua Zhang
Non-Executive Director3.3yrs데이터 없음데이터 없음
Yikai Li
Independent Non-Executive Directorless than a year데이터 없음데이터 없음

4.0yrs

평균 재임 기간

53yo

평균 연령

경험이 풍부한 이사회: 1681 의 이사회경험(평균 재직 기간 4 년)으로 간주됩니다.